Eurofins Scientific SE/ FR0014000MR3 /
| 11/12/2024 5:39:03 PM | Chg. -0.750 | Volume | Bid3:02:22 AM | Ask3:02:22 AM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 45.400EUR | -1.63% | 450,293 Turnover: 20.5 mill. |
45.340Bid Size: 300 | 45.450Ask Size: 25 | 8.76 bill.EUR | 1.10% | 15.34 |
Assets
| 2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 686 | 1,018 | 1,593.5000 | 1,574.9000 | 1,829.9000 | ||||||
| Intangible Assets | 735.1000 | 946.9000 | 918.2000 | 825.1000 | 895.7000 | ||||||
| Long-Term Investments | 43.9000 | 67.6000 | 49.2000 | 51 | 81.7000 | ||||||
| Fixed Assets | - | - | - | - | 7,013.3000 | ||||||
| Inventories | 51.8000 | 66.4000 | 79.3000 | 157 | 154.2000 | ||||||
| Accounts Receivable | 705.7000 | 864.9000 | 1,001.2000 | 948.5000 | 1,051.8000 | ||||||
| Cash and Cash Equivalents | 820.4000 | 506.2000 | 297 | 912.4000 | 515.3000 | ||||||
| Current Assets | 1,826.6000 | 1,705.4000 | 1,604.1000 | 2,518.2000 | 2,319 | ||||||
| Total Assets | 5,832.3000 | 7,205.4000 | 7,823.1000 | 8,575.5000 | 9,332.3000 | ||||||
Liabilities
| 2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 301.9000 | 373 | 409.8000 | 542 | 627.6000 | ||||||
| Long-term debt | - | - | - | - | 2,500.3000 | ||||||
| Liabilities to Banks | 618.7000 | 457.1000 | 504.8000 | 288.9000 | - | ||||||
| Provisions | 126.4000 | 138.6000 | 124.5000 | 115.3000 | 168.5000 | ||||||
| Liabilities | 3,350.3000 | 4,483.3000 | 4,925 | 4,859.1000 | 4,655.1000 | ||||||
| Share Capital | 1.7640 | 1.7750 | 1.8000 | 1.9000 | - | ||||||
| Total Equity | 2,443.2000 | 2,669.2000 | 2,838.6000 | 3,690.3000 | 4,647.6000 | ||||||
| Minority Interests | 38.8000 | 53 | 59.5000 | 26.1000 | 29.5000 | ||||||
| Total liabilities equity | 5,832.3000 | 7,205.4000 | 7,823.1000 | 8,575.5000 | 9,332.3000 | ||||||
Income Statement
| 2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 2,971.4000 | 3,781.1000 | 4,562.8000 | 5,438.8000 | 6,717.7000 | ||||||
| Depreciation (total) | 175.7000 | 223.7000 | 395.9000 | 426 | 450.7000 | ||||||
| Operating Result | 296.8000 | 344 | 366.6000 | 800.3000 | 1,258.2000 | ||||||
| Interest Income | -47.1000 | -54.5000 | -95.7000 | -107.7000 | -203.7000 | ||||||
| Income Before Taxes | 250.1000 | 289.8000 | 271.5000 | 694.4000 | 1,056.6000 | ||||||
| Income Taxes | 31.3000 | 66.3000 | 76.3000 | 153.9000 | 273.6000 | ||||||
| Minority Interests Profit | -2.1000 | .4000 | 0.0000 | 0.0000 | .4000 | ||||||
| Net Income | 216.8000 | 224 | 195.2000 | 540.5000 | 782.6000 | ||||||
Per Share
Cash Flow
| 2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 405.1000 | 543.9000 | 677.9000 | 1,223.5000 | 1,511.4000 | ||||||
| Cash Flow from Investing Activities | -1,747.1000 | -1,557.4000 | -540.2000 | -525 | -1,021 | ||||||
| Cash Flow from Financing | 1,343.3000 | 691.1000 | -342.2000 | -48.6000 | -910.3000 | ||||||
| Decrease / Increase in Cash | -9.6000 | -321 | -200.5000 | 616 | - | ||||||
| Employees | 28,259 | 36,518 | 43,320 | 51,516 | 57,992 | ||||||
